Articles
-
Schaeffer Center Economic Modeling Contributes to National Academy Report on Diversity in Clinical Trials
Populations underrepresented in clinical trials face worse health outcomes that will cost the U.S. trillions of dollars over the next three decades.
Categorized in -
Value Defects In The Health Services Sector
As of 2021, US health care expenditures exceed $3.8 trillion. It’s no secret that health care is nearly as wasteful in spending on value defects—behaviors that needlessly reduce quality, negatively impact the patient experience, or add to total costs of care—as it is in delivering clinical benefits.
Categorized in -
USC Schaeffer’s Rocio Ribero Was a Deep Thinker Who Loved Laughter, Her Family and Solving Problems
USC Price is remembering Rocio Ribero, a research scientist who produced groundbreaking work in the Schaeffer Center for Health Policy and Economics.
Categorized in -
Biomedical Expert Designs Health Dataset Representing All Demographic Groups
Although big data is revolutionizing healthcare, its potential has been limited by underrepresentation of vulnerable populations, including marginalized racial and socioeconomic groups that are at higher risk for poor health outcomes.
Categorized in -
Who Is Really Driving Up Insulin Costs?
In the long term, capping insulin payments at $35 a month is just shuffling the deck rather than changing the game of insulin costs.
Categorized in -
Before Prescribing Opioids, Draft a Deprescribing Plan
To get past the allure of continued and often troublesome opioid use patterns, patients and doctors need a plan in hand before the first opioid is ever used.
Categorized in -
Schaeffer Expert Warns of Lax Regulation of U.S. Cannabis Market at U.N. Event
Rosalie Liccardo Pacula presented findings at the U.N. Commission on Narcotic Drugs side event.
Categorized in -
Stabilizing Health Care’s Share of the GDP
Since 1960, health care’s share of the GDP has risen by an average of 2.2 percentage points per decade, as compared with an average increase of 1.1 percentage points per decade in 15 other high-income countries since the early 1970s.
Categorized in -
Study Finds Older Americans Are Largely Unaware of a New Alzheimer’s Drug
Among older Americans surveyed in the weeks after FDA approval of aducanumab, few could correctly answer true or false questions about the first new Alzheimer’s drug in decades.
-
Injuries Due to Medical Error are Common. They Could Be Prevented by Reducing Complexity
Research shows that medical error is the third leading cause of death worldwide.
Categorized in